| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase II sequence-specific DNA-binding transcription factor recruiting activity | 8.29e-06 | 4 | 24 | 2 | GO:0001010 | |
| GeneOntologyMolecularFunction | odorant binding | 4.61e-04 | 127 | 24 | 3 | GO:0005549 | |
| GeneOntologyMolecularFunction | lysine-acetylated histone binding | 5.90e-04 | 30 | 24 | 2 | GO:0070577 | |
| GeneOntologyMolecularFunction | acetylation-dependent protein binding | 6.30e-04 | 31 | 24 | 2 | GO:0140033 | |
| GeneOntologyMolecularFunction | olfactory receptor activity | 1.61e-03 | 431 | 24 | 4 | GO:0004984 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | 3.54e-03 | 884 | 24 | 5 | GO:0004930 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | 4.47e-03 | 1353 | 24 | 6 | GO:0004888 | |
| GeneOntologyBiologicalProcess | negative regulation of endodermal cell fate specification | 7.13e-06 | 4 | 23 | 2 | GO:0042664 | |
| GeneOntologyBiologicalProcess | regulation of endodermal cell fate specification | 1.19e-05 | 5 | 23 | 2 | GO:0042663 | |
| GeneOntologyBiologicalProcess | negative regulation of endodermal cell differentiation | 1.78e-05 | 6 | 23 | 2 | GO:1903225 | |
| GeneOntologyBiologicalProcess | negative regulation of cell fate specification | 3.32e-05 | 8 | 23 | 2 | GO:0009996 | |
| GeneOntologyBiologicalProcess | regulation of endodermal cell differentiation | 5.32e-05 | 10 | 23 | 2 | GO:1903224 | |
| GeneOntologyBiologicalProcess | endodermal cell fate specification | 6.50e-05 | 11 | 23 | 2 | GO:0001714 | |
| GeneOntologyBiologicalProcess | cell dedifferentiation | 1.24e-04 | 15 | 23 | 2 | GO:0043697 | |
| GeneOntologyBiologicalProcess | dedifferentiation | 1.24e-04 | 15 | 23 | 2 | GO:0043696 | |
| GeneOntologyBiologicalProcess | negative regulation of cell fate commitment | 1.60e-04 | 17 | 23 | 2 | GO:0010454 | |
| GeneOntologyBiologicalProcess | endodermal cell fate commitment | 1.80e-04 | 18 | 23 | 2 | GO:0001711 | |
| GeneOntologyBiologicalProcess | regulation of stem cell division | 1.80e-04 | 18 | 23 | 2 | GO:2000035 | |
| GeneOntologyBiologicalProcess | renal sodium ion transport | 1.80e-04 | 18 | 23 | 2 | GO:0003096 | |
| GeneOntologyBiologicalProcess | mesodermal cell fate commitment | 2.97e-04 | 23 | 23 | 2 | GO:0001710 | |
| GeneOntologyBiologicalProcess | regulation of cell fate specification | 4.74e-04 | 29 | 23 | 2 | GO:0042659 | |
| GeneOntologyBiologicalProcess | negative regulation of stem cell differentiation | 6.15e-04 | 33 | 23 | 2 | GO:2000737 | |
| GeneOntologyBiologicalProcess | mesodermal cell differentiation | 6.92e-04 | 35 | 23 | 2 | GO:0048333 | |
| GeneOntologyBiologicalProcess | cell fate commitment involved in formation of primary germ layer | 7.74e-04 | 37 | 23 | 2 | GO:0060795 | |
| GeneOntologyBiologicalProcess | endodermal cell differentiation | 8.16e-04 | 38 | 23 | 2 | GO:0035987 | |
| GeneOntologyCellularComponent | mitotic spindle midzone | 1.38e-04 | 16 | 23 | 2 | GO:1990023 | |
| GeneOntologyCellularComponent | Flemming body | 7.13e-04 | 36 | 23 | 2 | GO:0090543 | |
| GeneOntologyCellularComponent | spindle midzone | 8.81e-04 | 40 | 23 | 2 | GO:0051233 | |
| GeneOntologyCellularComponent | mitotic spindle pole | 1.02e-03 | 43 | 23 | 2 | GO:0097431 | |
| GeneOntologyCellularComponent | cleavage furrow | 2.04e-03 | 61 | 23 | 2 | GO:0032154 | |
| GeneOntologyCellularComponent | cell division site | 3.47e-03 | 80 | 23 | 2 | GO:0032153 | |
| MousePheno | abnormal white adipose tissue morphology | 5.52e-05 | 321 | 19 | 5 | MP:0002970 | |
| MousePheno | absent primitive endoderm | 6.27e-05 | 9 | 19 | 2 | MP:0011185 | |
| MousePheno | absent extraembryonic ectoderm | 1.82e-04 | 15 | 19 | 2 | MP:0002583 | |
| MousePheno | absent embryonic epiblast | 2.08e-04 | 16 | 19 | 2 | MP:0011184 | |
| MousePheno | decreased white adipose tissue amount | 2.32e-04 | 90 | 19 | 3 | MP:0001783 | |
| Domain | - | 2.96e-04 | 20 | 24 | 2 | 3.60.15.10 | |
| Domain | Metallo-B-lactamas | 2.96e-04 | 20 | 24 | 2 | IPR001279 | |
| Domain | GPCR_Rhodpsn_7TM | 1.41e-03 | 670 | 24 | 5 | IPR017452 | |
| Domain | Olfact_rcpt | 1.47e-03 | 393 | 24 | 4 | IPR000725 | |
| Domain | 7tm_1 | 1.48e-03 | 677 | 24 | 5 | PF00001 | |
| Domain | G_PROTEIN_RECEP_F1_1 | 1.56e-03 | 685 | 24 | 5 | PS00237 | |
| Domain | G_PROTEIN_RECEP_F1_2 | 1.62e-03 | 691 | 24 | 5 | PS50262 | |
| Domain | GPCR_Rhodpsn | 1.63e-03 | 692 | 24 | 5 | IPR000276 | |
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 24598770 | ||
| Pubmed | Differential expression of nanog1 and nanogp8 in colon cancer cells. | 4.56e-07 | 2 | 24 | 2 | 22079639 | |
| Pubmed | Expression of NANOG and NANOGP8 in a variety of undifferentiated and differentiated human cells. | 4.56e-07 | 2 | 24 | 2 | 21136380 | |
| Pubmed | Functional evidence that the self-renewal gene NANOG regulates human tumor development. | 4.56e-07 | 2 | 24 | 2 | 19415763 | |
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 25825768 | ||
| Pubmed | Epithelial cell senescence induces pulmonary fibrosis through Nanog-mediated fibroblast activation. | 1.37e-06 | 3 | 24 | 2 | 31891567 | |
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 23200040 | ||
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 19447925 | ||
| Pubmed | Selenium Augments microRNA Directed Reprogramming of Fibroblasts to Cardiomyocytes via Nanog. | 1.37e-06 | 3 | 24 | 2 | 26975336 | |
| Pubmed | Nanog suppresses cell migration by downregulating thymosin β4 and Rnd3. | 1.37e-06 | 3 | 24 | 2 | 23329853 | |
| Pubmed | The pluripotency factor NANOG controls primitive hematopoiesis and directly regulates Tal1. | 1.37e-06 | 3 | 24 | 2 | 30814124 | |
| Pubmed | Identification of two distinct transactivation domains in the pluripotency sustaining factor nanog. | 1.37e-06 | 3 | 24 | 2 | 14728807 | |
| Pubmed | Locating and Characterizing a Transgene Integration Site by Nanopore Sequencing. | 1.37e-06 | 3 | 24 | 2 | 30837263 | |
| Pubmed | NANOG alone induces germ cells in primed epiblast in vitro by activation of enhancers. | 1.37e-06 | 3 | 24 | 2 | 26751055 | |
| Pubmed | Isolation and characterization of the murine Nanog gene promoter. | 1.37e-06 | 3 | 24 | 2 | 15916719 | |
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 25173648 | ||
| Pubmed | Distinct Contributions of Tryptophan Residues within the Dimerization Domain to Nanog Function. | 1.37e-06 | 3 | 24 | 2 | 27939294 | |
| Pubmed | Epigenetic regulation of Nanog gene in embryonic stem and trophoblast stem cells. | 1.37e-06 | 3 | 24 | 2 | 17352742 | |
| Pubmed | The molecular logic of Nanog-induced self-renewal in mouse embryonic stem cells. | 1.37e-06 | 3 | 24 | 2 | 30846691 | |
| Pubmed | Generation of germline-competent induced pluripotent stem cells. | 1.37e-06 | 3 | 24 | 2 | 17554338 | |
| Pubmed | Multiple phases in regulation of Nanog expression during pre-implantation development. | 1.37e-06 | 3 | 24 | 2 | 26660234 | |
| Pubmed | Nanog retrotransposed genes with functionally conserved open reading frames. | 1.37e-06 | 3 | 24 | 2 | 16845474 | |
| Pubmed | Nanog overcomes reprogramming barriers and induces pluripotency in minimal conditions. | 1.37e-06 | 3 | 24 | 2 | 21194951 | |
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 23178592 | ||
| Pubmed | Stochastic NANOG fluctuations allow mouse embryonic stem cells to explore pluripotency. | 1.37e-06 | 3 | 24 | 2 | 25005472 | |
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 24681518 | ||
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 16773043 | ||
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 23665121 | ||
| Pubmed | Ectopic overexpression of Nanog induces tumorigenesis in non-tumorous fibroblasts. | 1.37e-06 | 3 | 24 | 2 | 26733157 | |
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 22388986 | ||
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 16313224 | ||
| Pubmed | Crystal structure and DNA binding of the homeodomain of the stem cell transcription factor Nanog. | 1.37e-06 | 3 | 24 | 2 | 18177668 | |
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 26549484 | ||
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 23071603 | ||
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 16791199 | ||
| Pubmed | Expression of Nanog gene promotes NIH3T3 cell proliferation. | 1.37e-06 | 3 | 24 | 2 | 16259959 | |
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 16501172 | ||
| Pubmed | Effect of Nanog overexpression on the metastatic potential of a mouse melanoma cell line B16-BL6. | 1.37e-06 | 3 | 24 | 2 | 33665763 | |
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 12609610 | ||
| Pubmed | Heparan sulfate regulates self-renewal and pluripotency of embryonic stem cells. | 1.37e-06 | 3 | 24 | 2 | 18024963 | |
| Pubmed | Regulated fluctuations in nanog expression mediate cell fate decisions in embryonic stem cells. | 1.37e-06 | 3 | 24 | 2 | 19582141 | |
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 27125671 | ||
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 18442017 | ||
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 24227785 | ||
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 21119109 | ||
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 32145514 | ||
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 19703398 | ||
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 22028025 | ||
| Pubmed | Nanog safeguards pluripotency and mediates germline development. | 1.37e-06 | 3 | 24 | 2 | 18097409 | |
| Pubmed | Context-Dependent Functions of NANOG Phosphorylation in Pluripotency and Reprogramming. | 1.37e-06 | 3 | 24 | 2 | 28457890 | |
| Pubmed | Nanog Fluctuations in Embryonic Stem Cells Highlight the Problem of Measurement in Cell Biology. | 1.37e-06 | 3 | 24 | 2 | 28636920 | |
| Pubmed | Requirement of Nanog dimerization for stem cell self-renewal and pluripotency. | 1.37e-06 | 3 | 24 | 2 | 18436640 | |
| Pubmed | Heterogeneities in Nanog Expression Drive Stable Commitment to Pluripotency in the Mouse Blastocyst. | 1.37e-06 | 3 | 24 | 2 | 25753417 | |
| Pubmed | Stochastic promoter activation affects Nanog expression variability in mouse embryonic stem cells. | 1.37e-06 | 3 | 24 | 2 | 25410303 | |
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 24929238 | ||
| Pubmed | Nanog and transcriptional networks in embryonic stem cell pluripotency. | 1.37e-06 | 3 | 24 | 2 | 17211451 | |
| Pubmed | The pluripotency factor nanog promotes breast cancer tumorigenesis and metastasis. | 1.37e-06 | 3 | 24 | 2 | 23770853 | |
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 15502159 | ||
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 20539761 | ||
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 33334884 | ||
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 21499299 | ||
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 20574542 | ||
| Pubmed | lincRNAs act in the circuitry controlling pluripotency and differentiation. | 1.37e-06 | 3 | 24 | 2 | 21874018 | |
| Pubmed | Cell signalling regulates dynamics of Nanog distribution in embryonic stem cell populations. | 1.37e-06 | 3 | 24 | 2 | 23054952 | |
| Pubmed | Phosphorylation of NANOG by casein kinase I regulates embryonic stem cell self-renewal. | 1.37e-06 | 3 | 24 | 2 | 33107035 | |
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 18584034 | ||
| Pubmed | Nanog-independent reprogramming to iPSCs with canonical factors. | 1.37e-06 | 3 | 24 | 2 | 24527385 | |
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 21969378 | ||
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 18086680 | ||
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 20661723 | ||
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 29245050 | ||
| Pubmed | Forced expression of Nanog in hematopoietic stem cells results in a gammadeltaT-cell disorder. | 1.37e-06 | 3 | 24 | 2 | 17360937 | |
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 22337995 | ||
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 21187909 | ||
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 27315375 | ||
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 35976266 | ||
| Pubmed | Functional analysis of two Sp1/Sp3 binding sites in murine Nanog gene promoter. | 1.37e-06 | 3 | 24 | 2 | 16541131 | |
| Pubmed | Role of Nanog in the maintenance of marrow stromal stem cells during post natal bone regeneration. | 1.37e-06 | 3 | 24 | 2 | 22142851 | |
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 18290762 | ||
| Pubmed | NANOG amplifies STAT3 activation and they synergistically induce the naive pluripotent program. | 1.37e-06 | 3 | 24 | 2 | 24462001 | |
| Pubmed | Reprogramming of mouse fibroblasts into induced pluripotent stem cells with Nanog. | 1.37e-06 | 3 | 24 | 2 | 23333380 | |
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 16790525 | ||
| Pubmed | Primitive endoderm differentiates via a three-step mechanism involving Nanog and RTK signaling. | 1.37e-06 | 3 | 24 | 2 | 22172669 | |
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 26760119 | ||
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 17204467 | ||
| Pubmed | CrxOS maintains the self-renewal capacity of murine embryonic stem cells. | 1.37e-06 | 3 | 24 | 2 | 19800316 | |
| Pubmed | Nanog is dispensable for the generation of induced pluripotent stem cells. | 1.37e-06 | 3 | 24 | 2 | 24461999 | |
| Pubmed | Nanog-dependent feedback loops regulate murine embryonic stem cell heterogeneity. | 1.37e-06 | 3 | 24 | 2 | 23103910 | |
| Pubmed | Aggregation of embryonic stem cells induces Nanog repression and primitive endoderm differentiation. | 1.37e-06 | 3 | 24 | 2 | 15494369 | |
| Pubmed | 2.74e-06 | 4 | 24 | 2 | 25743411 | ||
| Pubmed | 2.74e-06 | 4 | 24 | 2 | 16166633 | ||
| Pubmed | Cutting Edge: NANOG Activates Autophagy under Hypoxic Stress by Binding to BNIP3L Promoter. | 2.74e-06 | 4 | 24 | 2 | 28093523 | |
| Pubmed | 2.74e-06 | 4 | 24 | 2 | 22315219 | ||
| Pubmed | 2.74e-06 | 4 | 24 | 2 | 21304588 | ||
| Pubmed | Repression of Nanog gene transcription by Tcf3 limits embryonic stem cell self-renewal. | 2.74e-06 | 4 | 24 | 2 | 16894029 | |
| Pubmed | GATA-1 directly regulates Nanog in mouse embryonic stem cells. | 2.74e-06 | 4 | 24 | 2 | 26296469 | |
| Pubmed | 2.74e-06 | 4 | 24 | 2 | 17518637 | ||
| Pubmed | 2.74e-06 | 4 | 24 | 2 | 22787153 | ||
| Pubmed | 2.74e-06 | 4 | 24 | 2 | 20071344 | ||
| Pubmed | 2.74e-06 | 4 | 24 | 2 | 22683858 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p21 | 2.27e-03 | 135 | 24 | 2 | chr8p21 | |
| GeneFamily | NKL subclass homeoboxes and pseudogenes | 1.99e-03 | 67 | 18 | 2 | 519 | |
| GeneFamily | Olfactory receptors, family 2 | 5.55e-03 | 113 | 18 | 2 | 149 | |
| GeneFamily | WD repeat domain containing | 2.75e-02 | 262 | 18 | 2 | 362 | |
| Disease | colon cancer (implicated_via_orthology) | 2.64e-05 | 11 | 21 | 2 | DOID:219 (implicated_via_orthology) | |
| Disease | Alopecia | 8.19e-05 | 19 | 21 | 2 | C0002170 | |
| Disease | Cleft Palate | 1.51e-03 | 81 | 21 | 2 | C0008925 | |
| Disease | Profound Mental Retardation | 4.36e-03 | 139 | 21 | 2 | C0020796 | |
| Disease | Mental deficiency | 4.36e-03 | 139 | 21 | 2 | C0917816 | |
| Disease | Mental Retardation, Psychosocial | 4.36e-03 | 139 | 21 | 2 | C0025363 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LHLPMGPCYNLQPQA | 1026 | Q5JTC6 | |
| NLVLPSNGSMHNYCP | 56 | P25101 | |
| LRMILPNPLYHCLGS | 301 | Q96CM8 | |
| MKLYCLSGHPTLPCN | 1 | Q9NV88 | |
| CNPLLHTPMYFLLGN | 61 | Q8NGC9 | |
| GPSLPPDCHLLYAQM | 1156 | O43593 | |
| YHQGCLVNPTGNLPM | 181 | Q9H9S0 | |
| FHSLFNPMLNPLICS | 276 | Q96R45 | |
| FHSLFNPMLNPLICS | 276 | O95047 | |
| PQLHSPMYFFLGNLS | 51 | Q9UGF7 | |
| YPPAIPHNLSCLMNL | 121 | Q99062 | |
| ANHCPGAVMILFYLP | 791 | Q6PJP8 | |
| GNTSCLLHYMPQAPS | 306 | O43889 | |
| YLMPGFIHLVLQPSL | 296 | Q9NXZ2 | |
| CHGNTLLPQFLGMYR | 176 | Q8TBX8 | |
| YLPGMLHSNCPKGLL | 746 | Q8ND04 | |
| YHQGCLVNPTGNLPM | 181 | Q6NSW7 | |
| CLMNYFPLAPFNQLL | 506 | Q9NYY8 | |
| NCYFLHPPMPALLQL | 246 | Q9BQG2 | |
| MNLLPCNPHGNGLLY | 1 | Q5MNZ6 | |
| DPYNLAICFGPTLMH | 651 | O43295 | |
| PNYPAALMNLGAILH | 776 | Q8N394 | |
| AGCHPNPMKLLNYNP | 281 | Q15166 | |
| LMLPGYNQPACKLSH | 846 | Q9Y4E6 |